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Different phenotypes of wheezing have been described to date but not in early life. We aim
to describe wheezing phenotypes between the ages of two months and one year, and
assess risk factors associated with these wheezing phenotypes in a large birth cohort.
Methods
We studied 18,041 infants from the ELFE (French Longitudinal Study of Children) birth
cohort. Parents reported wheezing and respiratory symptoms at two and 12 months, and
answered a complete questionnaire (exposure during pregnancy, parental allergy).
Results
Children with no symptoms (controls) accounted for 77.2%, 2.1% had had wheezing at two
months but no wheezing at one year (intermittent), 2.4% had persistent wheezing, while
18.3% had incident wheezing at one year. Comparing persistent wheezing to controls
showed that having one sibling (ORa = 2.19) or 2 siblings (ORa = 2.23) compared to none,
nocturnal cough (OR = 5.2), respiratory distress (OR = 4.1) and excess bronchial secretions
(OR = 3.47) at two months, reflux in the child at 2 months (OR = 1.55), maternal history of
asthma (OR = 1.46) and maternal smoking during pregnancy (OR = 1.57) were significantly
associated with persistent wheezing. These same factors, along with cutaneous rash in the
child at 2 months (OR = 1.13) and paternal history of asthma (OR = 1.32) were significantly
associated with increased odds of incident wheezing. Having one sibling (ORa = 1.9) com-
pared to none, nocturnal cough at 2 months (OR = 1.76) and excess bronchial secretions at
2 months (OR = 1.65) were significantly associated with persistent compared to intermittent
wheezing.
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Conclusion
Respiratory symptoms (cough, respiratory distress, and excessive bronchial secretion)
were significantly associated with a high risk of persistent wheezing at one year. Smoking
exposure during pregnancy was also a risk factor for persistent and incident wheezing.
Introduction
Asthma is one of the most common chronic diseases worldwide with an estimated 300 million
individuals affected [1]. In clinical practice, asthma causes symptoms such as wheezing, short-
ness of breath, chest tightness, and coughing that vary over time in their occurrence, frequency,
and intensity. However, a proper asthma diagnosis cannot be based on a single common feature
[2, 3]. Currently, the intermittent symptoms of asthma are known to occur on a background of
persistent airway inflammation and remodeling [4]. Asthma is no longer considered as just one
disease but rather a multifaceted one, with multiple associated syndromes expressing different
phenotypes [5]. Therefore, increasing knowledge of these phenotypes will provide better under-
standing of the disease in order to better assist and manage patients [5].
Approximately 25 to 30 percent of infants will have at least one episode of wheezing during
their lifetime [6]. Children with persistent asthma may have reduced lung function, and some
are at risk of accelerated decline in lung function in early adult life [7]. Irregularities in pulmo-
nary function that are correlated with persistent wheezing become recognized during early
childhood and continue into adult life, suggesting that early life exposures are critical in deter-
mining the onset and natural history of wheezing disorders [8–10]. The etiology of wheezing is
usually difficult to ascertain, and wheezing is not specific for asthma and could be due to viral
infection [11], or environmental exposure (such as smoking) [12]. The number of wheezing
episodes in childhood seems to have an impact as outcomes are generally quite good in chil-
dren with small number of wheezing episodes associated with viral illness [13].
The severity of symptoms has been correlated with a high frequency of wheezing episodes
(usually more than three per year), resulting in the identification of frequent wheezing as a dis-
tinct phenotype [14–16]. Better understanding of the respiratory phenotypes in early child-
hood is of fundamental importance in addressing the risk factors for asthma and wheezing
illnesses in children [8–10]. Four wheezing phenotypes (no wheezing, transient-early, late-
onset, and persistent wheezing) were previously defined according to whether the child had
reported wheezing during the first three years of life and whether they were still wheezing at
age six [6]. Two British cohort studies used latent class analysis to identify distinct phenotypes
underlying the observed heterogeneity in asthma symptoms during childhood [17, 18]. The
Avon Longitudinal Study of Parents and Children (ALSPAC) identified six wheezing pheno-
types in childhood from birth to seven years old [17]. However, it is unclear whether pheno-
types identified by latent class analysis are comparable between birth cohorts observed in
different areas or countries, particularly because the number and timing of measurements, def-
initions of wheezing, and population characteristics may differ between studies [19–21].
ELFE (French Longitudinal Study of Children) is the first large-scale French longitudinal
birth cohort. The future follow-ups of the ELFE cohort will permit to derive phenotypes of
wheezing throughout childhood and assess association with the development of asthma. How-
ever, to date, there is scarce available data on the distribution and change in respiratory symp-
toms at a very early age. Phenotypes of wheeze during the first year of life have not been
studied before. The ELFE cohort comprises data on respiratory symptoms at two months and
one year of age.
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The aim of the present study was to characterize early wheezing phenotypes in infants, and
identify risk factors associated with these phenotypes in a large French birth cohort.
Methods
A representative random sample of mothers from maternity hospitals throughout France was
established. The target population consisted of every one in 50 children born in 2011 in French
maternity units [22]. After a written informed consent was obtained, medical records of the
mother were consulted. The mother then answered a general questionnaire about the health of
the baby and mental, social, family, and environmental exposures at age one. Follow-up is
planned until age 18. The children were selected to represent all seasons of the year, having
been born between April 1–4, June 27—July 4, September 27—October 4, and November 28—
December 5, 2011. The exclusion criteria were: prematurity, childbirth under 18 years old, and
no response to the questionnaire after two months. Mothers with multiple pregnancies with
more than two children and those unable to give informed consent in one of the languages in
which the information and consent forms were translated were also excluded.
Before the study began in 2011, a pilot study started in 2006–2007 in a small cohort
(n = 470) to test the different parts of the study, and the questionnaires. Questions showing
poor completion rates or that were not well understood by the participants were removed or
corrected. Before the study, a training course was organized for the investigators (question-
naire, filters inside the questionnaire). Investigators traveled to maternity units and undertook
the study in person with the parents. Initially, 18 322 children including 289 pairs of twins
were enrolled in the study at birth. Among the 18,322 selected families who gave their consent,
281 eventually refused to participate, leaving 18,041 families in the study. The children were
followed up at two months of age and then again at one year. At two months, trained investiga-
tors interviewed the parents in a face to face interview at home. When the child reached one
year old, parents answered a standardized questionnaire through a telephone conversation
conducted by specially trained professionals (phone-platforms currently involved in health
studies in France, by the French institute of statistics (INSEE)). By the time of the phone inter-
view, 4270 participants had been lost during the follow-up, leaving a total of 14059 children
included in the present analysis (Fig 1).
Wheezing phenotypes
Four groups were defined: non-wheezers (no current wheezing symptoms at both two months
and one year old), intermittent (current wheezing symptoms at two months but no wheezing
at one year), persistent (current wheezing at two months and at one year) and incident (no
current wheezing at two months but wheezing at one year). Wheezing at two months was
defined by a positive answer yes to the question “Does your child currently have wheezing or
whistling in the chest? “[23]. Wheezing at one year was defined by a positive answer to the
question “Does your child ever have wheezing or whistling in the chest? “
Risk factors
The questionnaire assessed the sociodemographic characteristics (age, gender, region, number
of rooms and number of persons living in the house, level of education for both parents), type
of delivery, Apgar scores at one and five minutes respectively, mother’s previous pregnancies,
and family history of asthma in parents and siblings of the child and other potential risk factors
of asthma (heating system used inside the house, dampness inside the house, work done dur-
ing pregnancy in the house, presence of pets in the house, child’s history of recurrent otitis,
rash history of the child, bronchiolitis, bronchitis episodes, and breastfeeding). Information
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concerning parental allergies was recorded by questions about family history of eczema,
asthma, eczema, and rhinitis (hay fever) for both parents and siblings. Finally, environmental
exposure to toxic substances was considered: smoking during pregnancy, passive smoking,
occupational and domestic pesticide exposure, and the use of cleaning products. Respiratory
symptoms at two months were taken into account. The presence of coughing was ascertained
by an affirmative answer to the question: “Has your child had a dry cough at night, apart from
a cough associated with a cold or chest infection?” To know whether the child had respiratory
problems, the following questions were used: “Has your child had any sign of respiratory dis-
tress?” and “At present does your child have any sign of respiratory distress?”. To investigate
the presence of excess bronchial secretions, the following questions were used: “Has your child
had an excess of bronchial secretion or phlegm?” and “At present are you noticing that your
child has an excess of bronchial secretion or phlegm?”. A question was further asking if the
child had ever been diagnosed with a bronchitis, and whether a doctor had prescribed medica-
tions, and a list of medications by class was proposed, to the parents.
Ethical approval
Each parent gave written informed consent at the maternity unit. Every level of the project and
each procedure was monitored by the National Council for Statistical Information (CNIS) and
approved by the French Data Protection Authority (CNIL), in conjunction with the Consulta-
tive Committee for Data Processing in Health Research (CCTIRS), which assesses the scientific
relevance of health projects, properly conducted from start to finish. Each parent retains the
right to withdraw his/her child at any point during the study.
Statistical analysis
Data analysis was performed by SPSS software, version 23. Two-sided statistical tests were
used to test the association of each respiratory symptom at two months across all four wheez-
ing groups; the Chi-2 test for dichotomous or multinomial qualitative variables, with Fisher’s
Fig 1. Flow chart.
https://doi.org/10.1371/journal.pone.0196711.g001
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exact test whenever appropriate. Regarding multivariate analysis, backward logistic regressions
were performed by taking into account the variables in the bivariate analysis that showed a p-
value <0.10 [24, 25];which included recommended covariates (such as maternal asthma,
smoking, and educational level of the mother used as a proxy for socio-economical status).
Educational level of the mother was categorized into 3 categories (low, intermediate and high
level). Number of siblings was categorized into 0 (reference), 1, 2 and “3 or more” siblings. Sev-
eral logistic regressions were conducted taking the dependent variables as follows: (1) intermit-
tent vs persistent wheezing, (2) non-wheezers vs persistent wheezers and (3) non-wheezers vs
incident wheezers.
Results
During the two-month survey, 146 families quit the study and 29 children were born outside
the dates of inclusion, reducing the total to 17,866 families. There were also 1295 non-respond-
ers, as well as 541 referent parents who did not answer the questions on the respiratory health
of their children, leaving a final total of 16,030 children (Fig 1).
Prevalence of wheezing and other respiratory symptoms at two months and
one year
Prevalence of wheezing was 6.5 percent at two months and reached 27.5 percent at one year.
The prevalence of nocturnal coughing increased from 25.5 percent to 67.5 percent between
two months and one year, signs of respiratory distress increased from 29.1 percent to 38.8 per-
cent and excess bronchial secretions from 34.7 percent to 65.1 percent respectively (Table 1).
A significantly higher proportion of children with wheezing at two months and nocturnal
coughing at two months were lost to follow-up, whereas a significantly higher proportion of
children with maternal eczema and paternal hay fever were still participating at the one-year
follow-up. There was no significant difference in patients lost to follow-up and those included
in regards to gender, signs of respiratory distress or excess bronchial secretion in the child at
two months, maternal history of asthma or hay-fever, and paternal history of asthma and
eczema (Table 2).
Wheezing phenotypes at one year
Children with no symptoms (controls) accounted for 77.2 percent, 2.1 percent had had wheez-
ing at two months but did not report wheezing at one year (intermittent), 2.4 percent had per-
sistent wheezing, while 18.3 percent had incident wheezing at one year.
Parental and infant factors associated with wheezing phenotypes
A significantly higher proportion of boys (59.5 percent) was observed among incident whee-
zers than among non wheezers (47.7%) (Table 3). Incident wheezers also showed a signifi-
cantly higher proportion of children who were delivered by caesarean (19.2 percent) (vs.
Table 1. Prevalence of wheezing and other respiratory symptoms at two months and one year in ELFE cohort.
Two months N = 15,896 One year N = 14,059
Wheezing 1026 (6.5%) 3871 (27.5%)
Nocturnal cough 4050 (25.5%) 9494 (67.5%)
Respiratory distress sign 4620 (29.1%) 5460 (38.8%)
Excess bronchial secretion 5519 (34.7%) 9155 (65.1%)
https://doi.org/10.1371/journal.pone.0196711.t001
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18.3% in non-wheezers), and a higher proportion of children with at least one sibling (60 per-
cent vs. 50% in non-wheezers). Having a nocturnal cough, signs of respiratory distress, and
excess bronchial secretions at two months were associated with wheezing at one year (persis-
tent wheezing). Persistent wheezers also comprise a significantly higher proportion of children
with at least one sibling as compared to non wheezers. Maternal atopy (i.e. asthma, eczema, or
Table 2. Comparison between children at one year and children lost to follow-up in ELFE cohort.
Included (N = 14059) Lost to follow-up Yes (N = 4270) Total (N = 18329) p-value
Gender
Male 7112 (51%) 2169 (52.4%) 9281 (51.3%) 0.227
Female 6813 (48.9%) 1966 (47.5%) 8779 (48.5%)
Wheezing in child at two months 830 (6.1%) 196 (8.7%) 1026 (6.5%) <0.001
Nocturnal cough in child at two months 3437 (25.2%) 613 (27.3%) 613 (27.3%) 0.037
Respiratory distress sign in child at two months 3954 (29%) 666 (29.6%) 4620 (29.1%) 0.537
Excess bronchial secretion in child at two months 4729 (34.7%) 790 (35.1%) 5519 (34.7%) 0.653
Maternal asthma 1629 (12%) 239 (11%) 1868 (11.8%) 0.43
Maternal eczema 2063 (15.1%) 280 (12.9%) 2343 (14.8%) 0.01
Maternal hay fever 2758 (20.2%) 400 (18.5%) 3158 (20%) 0.156
Paternal asthma 1477 (12.8%) 129 (11.6%) 1606 (12.6%) 0.414
Paternal eczema 1049 (9.1%) 93 (8.3%) 1142 (9%) 0.717
Paternal hay fever 2256 (19.5%) 159 (14.2%) 2415 (19%) <0.001
Mother’s educational level <0.001
Category 1 1997 (14.3%) 1379 (33.2%) 3376 (18.6%)
Category 2 2632 (18.8%) 1164 (28%) 3796 (20.9%)
Category 3 9361 (66.9%) 1608 (38.7%) 10969 (60.5%)
Age of the mother 31.03 ± 4.81 29.41 ± 5.63 <0.001
Number of siblings categories <0.001
None 6531 (46.5%) 2088 (48.9%) 8619 (47%)
1 4971 (35.4%) 1276 (29.9%) 6247 (34.1%)
2 1848 (13.1%) 540 (12.6%) 2388 (13%)
3 or more 709 (5%) 366 (8.6%) 1075 (5.9%)
 Category 1 includes illiteracy, primary and complementary levels of education; category 2 includes certificate of professional competence or professional qualifications,
technological baccalaureate and secondary level of education; category 3 includes university and higher university degrees.
https://doi.org/10.1371/journal.pone.0196711.t002
Table 3. Infant risk factors associated with wheezing phenotypes in ELFE cohort.
Variable Controls (N = 14151) Intermittent (N = 393) Persistent (N = 437) Incident (N = 3348) p-value
Nocturnal cough at two months 1954 (20.6%) 242 (61.6%) 338 (77.3%) 903 (27%) <0.0001
Respiratory distress signs at two months 2343 (24.7%) 279 (71%) 360 (82.4%) 972 (29%) <0.0001
Excess bronchial secretions at two months 2863 (30.2%) 294 (74.8%) 377 (86.3%) 1195 (35.7%) <0.0001
Gender <0.0001
Male 4661 (47.7%) 208 (53.6%) 266 (61.1%) 1977 (59.5%)
Female 5119 (52.3%) 180 (46.4%) 169 (38.9%) 1345 (40.5%)
Presence of bronchiolitis in child at two months 120 (5.5%) 43 (37.4%) 71 (43%) 41 (4.9%) <0.0001
Rash on the child’s skin at two months 1375 (14.5%) 74 (18.8%) 95 (21.7%) 559 (16.7%) <0.0001
Reflux in the child at 2 months 1854 (19.6%) 96 (24.4%) 131 (30%) 768 (22.9%) <0.0001
Results are expressed as frequency (percentage).
https://doi.org/10.1371/journal.pone.0196711.t003
Wheezing phenotypes in infants
PLOS ONE | https://doi.org/10.1371/journal.pone.0196711 April 27, 2018 6 / 15
hay fever) was also more frequent in persistent and incident wheezers. Smoking before and
during pregnancy were significantly associated with persistent wheezing respectively (Tables 3
and 4). No significant difference was found between the different wheezing phenotypes and
bronchitis, anti-asthma medication, and antibiotics taken by the child during the first year
(data not shown).
Risk factors and wheezing phenotypes: Multivariate analysis
The results of a first backward logistic regression taking the intermittent vs persistent wheezers
as the dependent variable, without entering the respiratory symptoms at 2 months as indepen-
dent variables (Table 5), showed that having 1 sibling (adjusted odds-ratio ORa = 2.15; 95%CI
1.50–3.09) or 2 siblings (ORa = 1.75; CI 1.08–2.82) compared to none were significantly associ-
ated with persistent wheezing.
Fig 2 shows the odds ratios from the logistic regression for persistent wheezing and incident
wheezing, as compared to non-wheezers. Female gender was associated with a decreased odds
of both persistent wheezing and incident wheezing with OR of similar magnitude (Fig 2). Con-
verserly, the presence of reflux in the child at 2 months, a maternal history of asthma and
maternal smoking during pregnancy were significantly associated with an increased risk of
both persistent and incident wheezing. Having 1, 2 or 3 or more siblings was a strong risk fac-
tor for persistent wheezing (with all OR>2.5) and was also associated with incident wheeze,
Table 4. Parental risk factors associated with wheezing phenotypes in ELFE cohort.
Variable Controls (N = 14151) Intermittent (N = 393) Persistent
(N = 437)
Incident (N = 3348) p-value
Maternal history of asthma 1006 (10.6%) 52 (13.3%) 80 (18.3%) 491 (14.7%) <0.0001
Maternal history of eczema 1369 (14.5%) 60 (15.3%) 69 (15.8%) 565 (16.9%) 0.01
Maternal history of hay fever 1827 (19.3%) 76 (19.4%) 112 (25.7%) 743 (22.3%) <0.0001
Paternal history of asthma 956 (11.9%) 39 (12.7%) 47 (13.7%) 435 (15.1%) <0.0001
Maternal smoking during pregnancy 1698 (17.4%) 85 (22%) 110 (25.5%) 657 (19.8%) <0.0001
Age of the mother at the child’s birth 30.99 ± 4.88 30.97 ± 4.93 30.71 ± 4.57 31.19 ± 4.58 0.062
Maternal educational level <0.0001
Category 1 1407 (14.3%) 73 (18.7%) 71 (16.3%) 446 (13.4%)
Category 2 1871 (19%) 86 (22%) 93 (21.4%) 582 (17.5%)
Category 3 6555 (66.7%) 232 (59.3%) 271 (62.3%) 2303 (69.1%)
Number of siblings <0.0001
None 4891 (49.5%) 165 (42%) 129 (29.5%) 1346 (40.2%)
1 3263 (33%) 146 (37.2%) 213 (48.7%) 1349 (40.3%)
2 1237 (12.5%) 57 (14.5%) 74 (16.9%) 480 (14.3%)
3 or more 490 (5%) 25 (6.4%) 21 (4.8%) 173 (5.2%)
Type of delivery 0.016
Spontaneous labor 6577 (68.5%) 262 (68.2%) 306 (72.2%) 2283 (69.9%)
Triggered childbirth 1269 (13.2%) 45 (11.7%) 42 (9.9%) 358 (11%)
Caesarean 1753 (18.3%) 77 (20.1%) 76 (17.9%) 626 (19.2%)
Exposure to tobacco smoke inside the house (yes) 1705 (17.3%) 76 (19.3%) 82 (18.8%) 537 (16%) 0.167
Detergent use in house 2793 (28.3%) 99 (25.2%) 127 (29.1%) 1002 (29.9%) 0.126
Use of toiletry products of animal origin 2223 (22.5%) 93 (23.7%) 90 (20.6%) 696 (20.8%) 0.146
Results are expressed as frequency (percentage) or mean ± Standard deviation.
 Category 1 includes illiteracy, primary and complementary levels of education; category 2 includes certificate of professional competence or professional
qualifications, technological baccalaureate and secondary level of education; category 3 includes university and higher university degrees.
https://doi.org/10.1371/journal.pone.0196711.t004
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although the association somewhat less strong. The presence of cutaneous rash in the child at 2
months was significantly associated with an increase in persistent wheezing.
When the respiratory symptoms at 2 months were entered in the model as independent
variables (Table 6), the first backward logistic regression taking the intermittent vs persistent
wheezers as the dependent variable, showed that the presence of a nocturnal cough in the child
at 2 months (ORa = 1.76; CI 1.19–2.60) and excess bronchial secretions in the child at 2
months (ORa = 1.65; CI 1.04–2.59) were associated with an increase in the odds of persistent
wheezing.
A second backward logistic regression, taking non-wheezers vs persistent wheezers, with
the respiratory symptoms at 2 months entered in the model as independent variables, showed
Table 5. Multivariable analysis.
Logistic regression 1 taking intermittent vs persistent wheezers as the dependent variable (without the
respiratory symptoms at 2 months as independent variables)
Variable p-value ORa Confidence
Interval
Number of siblings categories (compared to no siblings) <0.001
1 sibling <0.001 2.15 1.50 3.09
2 siblings 0.022 1.75 1.08 2.82
3 or more siblings 0.289 1.48 .71 3.10
Logistic regression 2 taking non-wheezers vs persistent wheezers as the dependent variable (without the
respiratory symptoms at 2 months as independent variables)
Variable p-value ORa Confidence
Interval
Gender (males vs females) <0.001 .60 .48 .75
Number of siblings categories (compared to no siblings) <0.001
1 sibling <0.001 3.18 2.43 4.17
2 siblings <0.001 2.98 2.07 4.30
3 or more siblings 0.001 2.57 1.46 4.50
Cutaneous rash in the child at 2 months <0.001 1.67 1.27 2.18
Reflux in the child at 2 months <0.001 1.83 1.43 2.33
Maternal history of asthma <0.001 1.64 1.21 2.23
Maternal smoking during pregnancy <0.001 1.67 1.28 2.16
Logistic regression 3 taking non-wheezers vs incident wheezers as the dependent variable (without the
respiratory symptoms at 2 months as independent variables)
Variable p-value ORa Confidence
Interval
Gender (males vs females) 0.018 .61 .55 .66
Number of siblings categories (compared to no siblings) 0.03
1 sibling 0.018 1.37 1.05 1.78
2 siblings 0.021 1.51 1.06 2.14
3 or more siblings 0.119 1.53 0.89 2.60
Reflux in the child at 2 months 0.019 1.38 1.05 1.80
Maternal history of asthma 0.044 1.42 1.01 1.97
Maternal smoking during pregnancy 0.039 1.35 1.01 1.79
 Reference group
-Variables entered in the models: maternal history of asthma, maternal history of eczema or hay fever, paternal
history of asthma, maternal smoking during pregnancy, type of delivery, gender, number of siblings categories, rash
on the child’s skin at 2 months, reflux in the child at 2 months, age of the mother at the child’s birth, educational level
of the mother.
https://doi.org/10.1371/journal.pone.0196711.t005
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that the presence of nocturnal cough in the child at 2 months (ORa = 5.2; CI 3.91–6.92), respi-
ratory distress in the child at 2 months (ORa = 4.1; CI 2.96–5.67) and the excess bronchial
secretions in the child at 2 months (ORa = 3.47; CI 2.41–4.98) were associated with an increase
in the odds of persistent wheezing.
A third backward logistic regression, taking non-wheezers vs incident wheezers, with the
respiratory symptoms at 2 months entered in the model as independent variables, showed that
the presence of nocturnal cough in the child at 2 months (ORa = 1.22; CI 1.09–1.36) was asso-
ciated with an increased odds of incident wheezing (Table 6).
Fig 2. Factors associated with persistent and incident wheezing at one year compared to non-wheezers (odds-ratios from backward logistic
regressions).
https://doi.org/10.1371/journal.pone.0196711.g002
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Discussion
In this large ELFE cohort, we found a high prevalence of respiratory symptoms in as early as
two months. We also assessed different risk factors and respiratory symptoms associated with
persistent wheezing at one year.
The percentage of children with respiratory symptoms at age two months and at one year
old was higher compared to the Columbia Center for Children’s Environmental Health
(CCCEH) (20.4 percent at age one) [26] and the ALSPAC [17] cohorts (26 percent at 18
Table 6. Multivariable analysis.
Logistic regression 1 taking intermittent vs persistent wheezers as the dependent variable (with the respiratory
symptoms at 2 months as independent variables).
Variable p-value ORa Confidence Interval
Number of siblings categories (compared to no siblings) .008
1 sibling 0.001 1.90 1.31 2.76
2 siblings 0.121 1.47 0.90 2.41
3 or more siblings 0.69 1.16 0.55 2.45
Nocturnal cough in the child at 2 months .005 1.76 1.19 2.60
Excess bronchial secretions in the child at 2 months .031 1.65 1.04 2.59
Logistic regression 2 taking non-wheezers vs persistent wheezers as the dependent variable.
Variable p-value ORa Confidence Interval
Gender (males vs females) <0.001 .63 .49 .81
Number of siblings categories (compared to no siblings) <0.001
1 sibling <0.001 2.19 1.65 2.90
2 siblings <0.001 2.23 1.53 3.24
3 or more siblings 0.03 1.92 1.06 3.46
Reflux in the child at 2 months .001 1.55 1.18 2.02
Maternal history of asthma .029 1.46 1.04 2.04
Maternal smoking during pregnancy .002 1.57 1.18 2.08
Nocturnal cough in the child at 2 months <0.001 5.20 3.91 6.92
Respiratory distress in the child at 2 months <0.001 4.10 2.96 5.67
Excess bronchial secretions in the child at 2 months <0.001 3.47 2.41 4.98
Logistic regression 3 taking non-wheezers vs incident wheezers as the dependent variable.
Variable p-value ORa Confidence Interval
Gender (males vs females) <0.001 .61 .55 .66
Cutaneous rash in the child at 2 months .037 1.13 1.01 1.28
Reflux in the child at 2 months .001 1.20 1.08 1.34
Maternal history of asthma <0.001 1.41 1.23 1.61
Paternal history of asthma <0.001 1.32 1.16 1.49
Maternal smoking during pregnancy .012 1.16 1.03 1.30
Maternal history of hay fever or eczema .016 1.13 1.02 1.24
Nocturnal cough in the child at 2 months <0.001 1.22 1.09 1.36
Excess bronchial secretions in the child at 2 months .063 1.10 .99 1.21
 Reference group
-Variables entered in the models: maternal history of asthma, maternal history of eczema or hay fever, paternal
history of asthma, maternal smoking during pregnancy, type of delivery, gender, number of siblings categories, rash
on the child’s skin at 2 months, reflux in the child at 2 months, age of the mother at the child’s birth, educational level
of the mother, nocturnal cough in the child at 2 months, respiratory distress in the child at 2 months, excess
bronchial secretions in the child at 2 months.
https://doi.org/10.1371/journal.pone.0196711.t006
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months old). A nocturnal cough, signs of respiratory distress, and excess bronchial secretion
symptoms continued to increase from two months old to one year. To our knowledge, no
other cohort has evaluated these three symptoms with the development of respiratory symp-
toms at age one. Time will reveal the association between each of these symptoms and asthma
at a later stage of these children’s lives. While all these symptoms are associated with an
increased risk of having persistent wheeze at one year, it’s interesting to note also that noctur-
nal cough at the age of 2 months is also associated with an increased likelihood of incident
wheeze at one year.
Nocturnal cough at two months, respiratory distress signs at two months, excess bronchial
secretions at two months increased the likelihood of persistent and incident wheezing in the
multivariate analysis. These symptoms could be due to allergenic inflammation, or inflamma-
tion related to environmental exposure to irritants in children exposed to a detrimental envi-
ronment. These symptoms could also be due to viral infection, or to bacterial infection
although endotoxin and other components of bacteria have been found to have a protective
effect for asthma at an older age (hygiene hypothesis) [27]. Furthermore, the same respiratory
symptoms may have different biological etiology.
Maternal smoking was associated with persistent wheezing (from two months to one year)
and incident wheezing at one year, in agreement with what was found in previous cohorts [6].
The association between maternal smoking and transient early wheezing may be mediated, at
least in part, by narrower airways in the children of women who smoke [6].
Parental asthma is thought to influence the risk of asthma in children [28]. However, hered-
itary patterns are multifaceted with many important questions remaining unanswered, such as
heredity effects at different ages [6, 29], and the potential additional effect of having relatives
with asthma. Our results indicate that a mother’s history of hay fever, eczema or asthma was
associated with an increased risk of persistent wheezing in children, corroborating previous
findings [30].
Furthermore, the increased number of siblings was associated with a decreased odds of per-
sistent wheezing compared to intermittent wheezing, which might be explained by a higher
risk of viral infection or contamination in children sharing their room with siblings. Indeed,
previous findings suggest that the increased number of children puts the entire household at
increased risk for infection with viruses that cause colds, flu, and other respiratory illnesses
[31]. In addition, an increase in childhood asthma may predispose to severe RSV infection
[32]. Meta-analyses have shown that delivery by caesarian section is associated with an
increased risk of asthma in the offspring [33, 34], with a close and bilateral link between hospi-
talization for respiratory syncytial virus and asthma [35, 36].
The relationship between gastroesophageal reflux disease (GERD) and asthma in children
has been investigated, although the nature of the association (if any) between them is unclear
[37]. A clinical study showed that GERD is highly predominant in children with asthma, with
estimations reaching as high as 80 percent, but nearly half of the children were asymptomatic;
a finding in agreement with ours [38].
We have defined a priori three wheezing phenotypes, similar to those of Spycher et al. [39].
In the ALSPAC and PIAMA cohorts, six and five phenotypes were identified respectively [40].
A recent latent class analysis including respiratory symptoms (wheeze, night cough, and rhini-
tis) and atopy in children aged 18 months from the Pollution and Asthma Risk Infant Study
identified a mild, a non-atopic severe and an atopic severe phenotype, respectively [41]. At age
one, we also defined a transient wheezing phenotype (intermittent wheezing), consistent with
the findings of Tucson [6]; since this phenotype is associated with having siblings, we can
hypothesize that it is possibly linked to viral infections.
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The strengths of our study include the early prospective documentation of respiratory
symptoms and wheezing in a large nationally representative cohort with adjustment for key
confounders including maternal asthma, exposure to smoking and maternal education and
number of siblings. The use of parental reporting to identify respiratory symptoms and wheez-
ing is a limitation, although we used an internationally standardized questionnaire. A selection
bias is possible because of the refusal rate and the exclusion criteria. Indeed, a premature child
or one from multiple pregnancies may exhibit respiratory or worse health at birth. In this case,
the associations between phenotypes and severity criteria could be underestimated. In the
French context, our inclusion criteria may have led to a selection bias with younger parents
more often born abroad and having a lower occupational status being excluded from the
study. Such women are more often single mothers and have a lower level of education than
the parents in our sample. This may have led to an under-estimation of the number of less
healthy children in our sample since children of such underprivileged mothers could have
been under-represented in our sample. Furthermore, we cannot rule out an information bias
since we used parent reporting. Another limitation of our study was the lack of viral measure-
ment by PCR, which was not possible in this large population of newborn children, or even in
a subsample of children because of the cost aspect.
However, the questionnaires were tested during pilot surveys, thus minimizing the infor-
mation bias. Further, a follow-up of the ELFE cohort is underway, including respiratory symp-
toms, pulmonary function testing, and formal examination at age 10. These assessments will
facilitate extended evaluation of the association between earlier wheezing phenotypes and sub-
sequent respiratory health.
Conclusion
We found a high prevalence of respiratory symptoms in early life with an increase in incident
wheezing at age one. Other respiratory symptoms (cough, respiratory distress, and excessive
bronchial secretion) were significantly associated with a higher risk of persistent wheezing.
Smoking exposure during pregnancy remains a known risk factor of persistent wheezing. Lon-
ger follow-up with symptoms, lung function and atopy markers are needed to derive wheezing
phenotypes throughout childhood and assess the relationships of these early-life symptoms
with asthma onset.
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